RecruitingNCT05888909

Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy


Sponsor

Chinese PLA General Hospital

Enrollment

2,000 participants

Start Date

Aug 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Diabetes nephropathy (DN) is one of the most serious microvascular complications of diabetes, and also an important cause of death and disability of diabetes patients. There is no specific clinical staging of type 2 diabetes nephropathy at home and abroad, and there is no comprehensive study to comprehensively describe the occurrence and development of type 2 diabetes nephropathy through sensitive biomarkers, microvascular disease imaging and functional detection, digital markers and other multi-dimensional diagnosis and evaluation methods. Therefore, our research aims to establish a long-term follow-up queue for the whole cycle of diabetes nephropathy, develop multi-dimensional diagnostic and progress digital markers for diabetes nephropathy, develop a multimodal non-invasive diagnostic model and a new clinical staging/typing, and create a multi-dimensional accurate diagnosis and treatment system for type 2 diabetes nephropathy combining traditional Chinese and western medicine.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting clinical data and tissue samples from patients with type 2 diabetes who also have kidney disease (diabetic nephropathy) to better understand how this condition develops and to improve diagnosis and treatment. **You may be eligible if...** - You are 18 years old or older - You have a diagnosis of type 2 diabetes - You have complete medical records available - If you had a kidney biopsy, a clear pathological diagnosis must have been made - You have voluntarily signed the informed consent form **You may NOT be eligible if...** - Your medical records are incomplete - You have a hereditary kidney disease - You have an active urinary tract infection - You have an autoimmune disease - You have cancer with a life expectancy of less than 6 months - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Chinese PLA General Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05888909


Related Trials